IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 289 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18,549 | -20.3% | 519 | -15.7% | 0.00% | 0.0% |
| Q4 2022 | $23,266 | +10.8% | 616 | +18.7% | 0.00% | 0.0% |
| Q2 2021 | $21,000 | -68.2% | 519 | -55.6% | 0.00% | -66.7% |
| Q4 2020 | $66,000 | +135.7% | 1,169 | +103.7% | 0.00% | +200.0% |
| Q3 2020 | $28,000 | -88.6% | 574 | -88.9% | 0.00% | -93.8% |
| Q1 2020 | $245,000 | -48.0% | 5,183 | -33.5% | 0.02% | -36.0% |
| Q4 2019 | $471,000 | +712.1% | 7,790 | +758.9% | 0.02% | +525.0% |
| Q3 2019 | $58,000 | 0.0% | 907 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $58,000 | +9.4% | 907 | +38.5% | 0.00% | 0.0% |
| Q1 2019 | $53,000 | +29.3% | 655 | -13.5% | 0.00% | 0.0% |
| Q4 2018 | $41,000 | +32.3% | 757 | +25.7% | 0.00% | +100.0% |
| Q3 2018 | $31,000 | +10.7% | 602 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $28,000 | -62.2% | 602 | -64.2% | 0.00% | -66.7% |
| Q1 2018 | $74,000 | -23.7% | 1,680 | -12.9% | 0.01% | -25.0% |
| Q4 2017 | $97,000 | -41.6% | 1,928 | -41.1% | 0.01% | -57.9% |
| Q3 2017 | $166,000 | +435.5% | 3,272 | +443.5% | 0.02% | +375.0% |
| Q2 2017 | $31,000 | +19.2% | 602 | -7.7% | 0.00% | 0.0% |
| Q1 2017 | $26,000 | -33.3% | 652 | -38.8% | 0.00% | -42.9% |
| Q3 2016 | $39,000 | +34.5% | 1,065 | -15.8% | 0.01% | 0.0% |
| Q2 2016 | $29,000 | -43.1% | 1,265 | 0.0% | 0.01% | -50.0% |
| Q1 2016 | $51,000 | +5000.0% | 1,265 | +8333.3% | 0.01% | – |
| Q4 2015 | $1,000 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |